Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Stage 4 Bladder Cancer 1 Year Survival Rate Explained
Stage 4 Bladder Cancer 1 Year Survival Rate Explained 4

A diagnosis of advanced bladder cancer can change your life. Knowing the 1-year survival statistics and new treatments helps patients and families make better choices.stage 4 bladder cancer 1 year survival rate.

At Liv Hospital, we know stage 4 bladder cancer is the most serious. It means cancer has spread to nearby tissues, lymph nodes, or distant organs. The 1-year survival rate is usually between 30% and 40%. But, how well you do can depend on how you respond to treatment and your overall health.

Getting this diagnosis is tough. Cancer has moved beyond the bladder to places like lymph nodes, bones, liver, or lungs. This makes treatment harder.

Key Takeaways

  • The 1-year survival rate for advanced bladder cancer is between 30% and 40%.
  • Individual outcomes vary based on treatment response and health factors.
  • Cancer at this stage has spread to distant lymph nodes, bones, liver, or lungs.
  • Treatment options are available to improve survival rates and quality of life.
  • Multidisciplinary care is key for managing advanced bladder cancer.

Understanding Stage 4 Bladder Cancer

Stage 4 Bladder Cancer 1 Year Survival Rate Explained
Stage 4 Bladder Cancer 1 Year Survival Rate Explained 5

When bladder cancer reaches stage 4, it’s a serious moment. At this point, the cancer has moved beyond the bladder. It might have reached other parts of the body.

Definition and Classification

Stage 4 bladder cancer has spread to distant lymph nodes, organs, or other body parts. This is key for figuring out the treatment and how likely it is to succeed. It’s called metastatic because it has moved from where it started.

Knowing the stage helps doctors understand how far the cancer has gone. The TNM staging system is used. It looks at the tumor size (T), if it’s in nearby lymph nodes (N), and if it has spread (M).

How Cancer Spreads Beyond the Bladder

Bladder cancer can grow through the bladder wall to nearby areas. It can also spread to places like the liver, lungs, bones, or other organs. It moves through direct invasion, lymphatic spread, or through the bloodstream.

Understanding how cancer spreads is key to knowing how to treat it. When it reaches distant sites, treatment gets more complex. It often needs a mix of therapies.

Difference Between Locally Advanced and Metastatic Disease

It’s important to tell the difference between locally advanced and metastatic bladder cancer. Locally advanced means the tumor has grown into or through the bladder wall but hasn’t spread far. Metastatic disease means it has spread to distant lymph nodes or organs, making it stage 4.

This difference affects treatment choices and how likely you are to recover. Metastatic disease usually needs more intense and widespread treatments.

Stage 4 Bladder Cancer 1 Year Survival Rate Statistics

Stage 4 Bladder Cancer 1 Year Survival Rate Explained
Stage 4 Bladder Cancer 1 Year Survival Rate Explained 6

The 1-year survival rate for stage 4 bladder cancer offers important insights. It helps patients, their families, and doctors make better treatment choices.

Current Survival Rate Data

Recent studies show the 1-year survival rate for stage 4 bladder cancer is between 30% and 40%. This means 30 to 40 out of 100 people with this cancer may live for at least a year after being diagnosed.

Survival rates can change based on many factors. These include the patient’s health, age, and how well they respond to treatment. These numbers are averages and should not be seen as a guarantee for any individual.

Factors Affecting Survival Statistics

Several things can impact survival rates for stage 4 bladder cancer. These include:

  • Age and Overall Health: Younger patients with fewer health issues usually have better survival chances.
  • Tumor Characteristics: The tumor’s aggressiveness and genetics can also play a role.
  • Response to Treatment: Patients who get better results from treatment tend to live longer.

How Survival Rates Are Calculated

Survival rates are based on data from cancer registries. These registries follow the outcomes of patients with certain cancers over time. The most common rate is the relative survival rate, which compares cancer patients’ survival to the general population.

Survival PeriodRelative Survival Rate
1 Year30-40%
3 Years10-20%
5 Years5-10%

Knowing how survival rates are calculated helps patients and families understand these numbers better. It aids in making informed decisions about care.

Comparing Survival Rates Across Different Stages

It’s important for patients to know how bladder cancer survival rates change with each stage. Bladder cancer is staged based on how far it has spread. The stage at diagnosis affects treatment options and survival chances.

Stage 3 vs. Stage 4 Survival Rates

Stage 3 and Stage 4 bladder cancer have different survival rates. For Stage 3, about 40% of patients live for 5 years after diagnosis. But for Stage 4, the survival rate is only around 10%. This shows how cancer spread affects survival chances.

Early detection and treatment are key. When cancer is caught early, treatments work better, leading to better survival rates.

Regional vs. Distant Metastasis Outcomes

How far cancer has spread also matters a lot. Regional metastasis means cancer has spread to nearby areas. Distant metastasis means it has spread to far-off parts of the body. Patients with regional metastasis usually do better than those with distant metastasis.

Knowing if cancer has spread regionally or distantly helps doctors plan better treatments. It also helps predict how well a patient might do.

Historical Trends in Bladder Cancer Survival

Bladder cancer survival rates have gotten better over time. This is thanks to new treatments and better ways to find cancer early. But, Stage 4 bladder cancer is harder to beat, with lower survival rates.

More research and new treatments are needed. They are key to improving survival rates, even for advanced bladder cancer.

Factors That Influence Individual Prognosis

Many things can change how well someone with stage 4 bladder cancer will do. Knowing these can help patients and their families make better choices about treatment.

Age and Overall Health

How old you are and your health matter a lot. Older people or those with health problems might not do as well. This is because they might not handle tough treatments as well.

Key health factors that influence prognosis include:

  • Presence of comorbidities such as diabetes or heart disease
  • Physical condition and performance status
  • Nutritional status and any significant weight loss

Tumor Characteristics

The type of tumor also affects how well someone will do. Things like how big the tumor is, its grade, and genetic changes can change how the cancer acts and how it reacts to treatment.

Tumor characteristics that affect prognosis include:

  1. Tumor stage and whether the cancer has spread to lymph nodes or distant sites
  2. Histological grade of the tumor
  3. Presence of specific biomarkers or genetic alterations

Response to Treatment

How well the cancer responds to treatment is very important. People who get better with treatment usually do better than those who don’t.

Factors influencing treatment response include:

  • Type and aggressiveness of the treatment regimen
  • Patient’s overall health and ability to tolerate treatment
  • Specific characteristics of the tumor

Genetic and Molecular Factors

Genetic and molecular factors are also key. Some genetic changes or expressions can affect how the cancer acts and how it reacts to treatments.

Examples of genetic and molecular factors include:

  1. Mutations in genes such as TP53 or RB1
  2. Expression of certain biomarkers that may predict treatment response
  3. Genomic instability and its impact on tumor behavior

Understanding these factors helps doctors give more tailored and effective care to those with stage 4 bladder cancer.

Life Expectancy Without Treatment

Knowing how long Stage 4 bladder cancer patients live without treatment is key. It helps families and patients make better choices about care and treatment.

Typical Progression Timeline

Without treatment, Stage 4 bladder cancer patients usually live 3 to 6 months. This time can change based on health, how far the cancer has spread, and other factors.

As Stage 4 bladder cancer gets worse, it can cause many problems. These issues can affect how well a patient lives. Knowing this helps plan for end-of-life care and support.

Symptoms and Quality of Life Considerations

As Stage 4 bladder cancer gets worse, symptoms can really hurt a patient’s quality of life. These symptoms include pain, trouble with urination, and feeling very tired. It’s important to manage these symptoms to keep patients comfortable and dignified.

Palliative care is key in helping with these symptoms. It aims to ease symptoms and stress from serious illnesses. This improves a patient’s quality of life.

Palliative Care Options

Palliative care for Stage 4 bladder cancer includes managing pain, controlling symptoms, and giving emotional support. These services can be given at home, in hospitals, or in special centers for palliative care.

  • Pain management through medication and other methods
  • Symptom control to make patients more comfortable and less stressed
  • Emotional and psychological support for patients and their families

By focusing on palliative care, patients with Stage 4 bladder cancer can have a better quality of life. This is true even without treatments that can cure the disease.

Treatment Options for Stage 4 Bladder Cancer

The treatment for stage 4 bladder cancer has changed, bringing new hope. Chemotherapy, immunotherapy, and other treatments are now available. It’s important to know about these options.

Chemotherapy Approaches

Chemotherapy is a key part of treating stage 4 bladder cancer. Systemic chemotherapy helps control symptoms and slow the disease. Treatments like gemcitabine plus cisplatin or the MVAC regimen are common.

While chemotherapy works well, it’s important to talk about side effects and benefits with your doctor.

Immunotherapy Innovations

Immunotherapy has changed how we treat bladder cancer, even in advanced stages. Immune checkpoint inhibitors like pembrolizumab and atezolizumab have shown great promise. They boost the immune system to fight cancer cells, often with fewer side effects than chemotherapy.

Radiation Therapy

Radiation therapy is another option for stage 4 bladder cancer, mainly for symptom relief. External beam radiation therapy (EBRT) is used to reduce pain or bleeding. Sometimes, it’s combined with other treatments to improve results.

Surgical Interventions

Surgery is not always the first choice for stage 4 bladder cancer. But, in some cases, cystectomy, or removing the bladder, might be considered. This is often with other treatments. Palliative surgeries can also help improve quality of life.

In summary, treating stage 4 bladder cancer requires a team effort. By understanding these options, patients can make better choices about their care.

How Treatment Impacts Survival Rates

Treatment for stage 4 bladder cancer has a big impact on survival rates. It involves many approaches tailored to each patient’s needs.

Treatment Response Patterns

It’s key to know how patients react to treatments. The way patients respond can differ a lot. This depends on their health, the tumor, and genetic markers.

Some patients see big improvements and live longer. Others might need changes in their treatment to get better results.

Combination Therapy Benefits

Using more than one treatment at a time can really help stage 4 bladder cancer patients. This mix of treatments, like chemotherapy and immunotherapy, can fight cancer better. It might lead to longer lives.

A study showed that mixing chemotherapy and immunotherapy can increase survival rates. This is better than using just one treatment.

Treatment Approach1-Year Survival Rate2-Year Survival Rate
Single-Modality Treatment40%20%
Combination Therapy60%40%

Clinical Trial Outcomes

Clinical trials are very important for finding new treatments for stage 4 bladder cancer. Recent trials have shown promising results. This gives hope for better survival rates.

For example, a trial on a new immunotherapy showed it greatly improved survival for advanced bladder cancer patients. This shows new treatments can make a big difference.

“The advent of combination therapies and immunotherapies has revolutionized the treatment landscape for stage 4 bladder cancer, opening up new ways to improve patient outcomes,” said Medical Expert, a leading oncologist specializing in bladder cancer treatment.

In conclusion, the treatment for stage 4 bladder cancer greatly affects survival rates. Understanding how patients respond, using combination therapies, and joining clinical trials can help. This way, doctors can give the best care and improve patient outcomes.

Is Bladder Cancer Terminal? Understanding Mortality

Stage 4 bladder cancer is a serious concern for patients. But knowing about mortality risk and survival chances is key. We’ll look at what affects survival and share stories of long-term survivors.

Mortality Risk Factors

Several things can affect how likely a stage 4 bladder cancer patient is to die. These include:

  • Age and Overall Health: Older patients or those with serious health issues usually face a tougher road.
  • Tumor Characteristics: How aggressive the tumor is and its genetic makeup play a big role in survival.
  • Response to Treatment: Patients who get better with initial treatment tend to do better overall.

Knowing these factors helps doctors give better predictions and tailor treatments for each patient.

Long-Term Survivors: Beating the Odds

Even though stage 4 bladder cancer is often seen as terminal, some beat the odds. What helps them include:

FactorDescriptionImpact on Survival
Aggressive TreatmentCombination therapies including chemotherapy, immunotherapy, and surgerySignificantly improves survival rates
Positive Response to Initial TreatmentEffective first-line treatmentEnhances overall survival
Genetic and Molecular FactorsFavorable genetic mutations or expressionsCan improve treatment response and survival

Long-term survivors often have a mix of these good factors. It’s important for patients to talk with their healthcare provider about their specific situation and treatment options.

By understanding what affects survival and learning from long-term survivors, patients and their families can face stage 4 bladder cancer better.

Living with Stage 4 Bladder Cancer

Being diagnosed with stage 4 bladder cancer means you need a detailed care plan. This includes managing symptoms and improving your quality of life. Understanding how this stage affects your daily life and well-being is key.

Managing Symptoms and Side Effects

Managing symptoms and side effects is essential for those with stage 4 bladder cancer. This requires both medical treatments and supportive care.

  • Symptom Management: Palliative care teams help reduce pain, nausea, and fatigue. This improves your quality of life.
  • Side Effect Mitigation: Chemotherapy and radiation can cause side effects. Managing these helps keep you comfortable and able to continue treatment.

A study in the Journal of Clinical Oncology found that palliative care improves outcomes and care satisfaction.

“Palliative care in advanced cancer improves quality of life and reduces symptoms.”

Quality of Life Considerations

Keeping your quality of life high is important when living with stage 4 bladder cancer. It’s not just about managing symptoms. It’s also about meeting your psychological, social, and emotional needs.

AspectConsiderations
Physical HealthPain management, symptom control, nutritional support
Emotional Well-beingCounseling, support groups, stress management techniques
Social SupportFamily support, social services, patient networks

Support Resources for Patients and Families

Stage 4 bladder cancer affects not just the patient but also their family. Having access to support resources is essential for coping.

Support Groups: Joining a support group offers a sense of community. It helps patients and families deal with cancer’s challenges.

Comprehensive Care: Having access to all-inclusive care, including palliative services, greatly improves your quality of life.

Conclusion

Knowing the 1-year survival rate for stage 4 bladder cancer is key for patients and their families. We’ve looked at what affects survival rates. This includes age, health, tumor details, and how well treatments work.

The 1-year survival rate for stage 4 bladder cancer is between 30% and 40%. Treatments like chemotherapy, immunotherapy, and radiation can greatly help. They can also improve life quality. By focusing on symptom management, patients can feel better overall.

In summary, treating stage 4 bladder cancer needs a full approach. We’ve seen that mixing therapies can boost survival chances. As we wrap up our talk on stage 4 bladder cancer, it’s vital to remember the importance of a survival rate summary. It helps patients understand their future.

By keeping up with new treatments and care improvements, patients with stage 4 bladder cancer can make better choices. This leads to a better life quality. This conclusion stresses the need for ongoing research and support for patients and their families.

FAQ

What is the 1-year survival rate for stage 4 bladder cancer?

The 1-year survival rate for stage 4 bladder cancer depends on several things. These include your overall health, the type of tumor, and how well you respond to treatment. We offer personalized insights into survival rates and treatment options.

How does stage 4 bladder cancer differ from earlier stages?

Stage 4 bladder cancer has spread to distant parts of the body. This makes treatment more challenging. Knowing this difference is key to finding the right treatment.

What factors influence individual prognosis for stage 4 bladder cancer?

Several factors affect your prognosis. These include your age, health, tumor type, treatment response, and genetic factors. We help you understand how these factors impact your prognosis.

What are the treatment options available for stage 4 bladder cancer?

Treatments include chemotherapy, immunotherapy, radiation, and surgery. Each has its benefits and side effects. We discuss these in detail to help you make informed decisions.

How does treatment impact survival rates for stage 4 bladder cancer?

Treatment response, combination therapy, and clinical trial outcomes all affect survival rates. Understanding these factors is key to improving care and survival chances.

Can you die from bladder cancer?

Yes, bladder cancer can be fatal, mainly if it spreads to distant organs. But, some patients survive long-term. We discuss factors that determine mortality risk and the importance of managing symptoms and maintaining quality of life.

What is life expectancy without treatment for stage 4 bladder cancer?

Life expectancy without treatment is generally poor. It depends on individual factors. We discuss the typical progression timeline and the importance of palliative care in managing symptoms and improving quality of life.

How can patients manage symptoms and maintain quality of life with stage 4 bladder cancer?

Managing symptoms and side effects is vital for quality of life. We provide guidance on support resources for patients and their families. We also discuss the importance of palliative care.

What is the difference between locally advanced and metastatic disease?

Locally advanced disease means cancer has spread to nearby tissues. Metastatic disease means it has spread to distant organs. Understanding this distinction is essential for choosing the best treatment.

Are there any new and innovative treatments available for stage 4 bladder cancer?

Yes, new treatments like immunotherapy are being explored. We discuss the latest developments and how they may change treatment options and survival rates.


References

National Center for Biotechnology Information What Is the 1Year Survival Rate for Stage. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903028/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 26 75